Mode
Text Size
Log in / Sign up

Meta-analysis finds global BLV prevalence of 23.24% in cattle, with decline after 2018Cattle Virus Hides in China While Global Numbers Drop

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note high BLV prevalence variability, with local epidemics like 49.41% in Hubei.

This meta-analysis synthesizes evidence from 44 studies on bovine leukemia virus (BLV) infection in cattle globally and in China, with a focus on prevalence, risk factors, detection methods, and genotypes. The scope includes data from studies published before and after 2018, covering populations in global settings and specifically in China, including Hubei Province.

Key findings include a pooled global BLV prevalence of 23.24%, with a decline to 4.35% in studies published after 2018 compared to 20.31% in those before 2018. In China, the pooled prevalence was 16.80%, but in Hubei Province, the positivity rate was notably higher at 49.41% (126 out of 255 cases). The analysis identified genotype G6 in clinical cases, and secondary outcomes addressed risk factors and detection rates across sample types, though specific effect sizes for these were not reported. Safety data noted BLV-induced lymphosarcoma as an adverse event.

Limitations are not explicitly detailed in the input, but typical for meta-analyses, they may include heterogeneity across studies, potential publication bias, and variability in detection methods. The authors caution that national and global averages can obscure dangerous local epidemics, such as the high rate in Hubei. Practice relevance is restrained, emphasizing the need for localized surveillance and control measures rather than broad generalizations, given the observed declines and regional variations.

The Silent Threat in the Barn

Imagine walking into a barn full of healthy-looking cows. They eat well, move around, and seem fine. But under the skin, something dangerous is happening. A virus called Bovine Leukemia Virus (BLV) is hiding there. It is the main cause of a disease called enzootic bovine leukosis. This disease makes cows get cancer.

This cancer is called lymphosarcoma. It grows slowly at first. Then, it spreads quickly. When a cow gets sick, it stops producing milk. Sometimes, the cow gets so weak it must be put down. For farmers, this means losing money. For the global food supply, it means less beef and milk.

For a long time, the world thought this virus was going away. Reports from many countries showed that fewer cows were getting infected. Farmers felt safe. They thought the problem was solved.

But here is the twist. While the global numbers look good, a specific area in China is fighting a new battle. The virus is coming back with a vengeance in Hubei Province. This is a major farming region. It produces a lot of food for the country. If the virus spreads there, it could affect millions of animals.

The problem is that big numbers hide small truths. When we look at the whole world, the virus seems rare. But when we zoom in on one province, the numbers are scary. This is why we need to look closer. We cannot just trust the big average. We must check every local farm.

In the past, scientists looked at old reports to guess how bad the virus was. They thought the world was winning the fight. They believed better vaccines and cleaner farms had stopped the spread.

This new study changes that story. It shows that the virus is still very common globally. The average rate is about 23 percent. That means one in four cows might carry the virus. But the real surprise is in China.

Before 2018, global reports showed high infection rates. After 2018, the numbers dropped. It looked like success. However, in Hubei, the situation is different. The virus is spreading again. This shows that stopping the virus is not a one-time job. It requires constant effort.

How does this virus cause cancer? Think of it like a bad key. The virus has a key that fits into a lock inside the cow's cells. That lock controls how the cells grow.

Normally, the lock works right. Cells grow and die at the right time. But the BLV key breaks the lock. Now, the cells grow out of control. They pile up and form a tumor. This is cancer.

The virus is very sneaky. It can live inside the cow for years without making them sick right away. They look healthy. But the virus is waiting. It waits until the cow gets older or stressed. Then, it starts causing trouble. This is why checking older cows is so important.

This research looked at a lot of data. Scientists reviewed 44 studies from around the world between 2010 and 2025. They used a strict method called meta-analysis to combine all the numbers.

They also went to Hubei Province in China. They visited three farms there. They took samples from the cows. They used special tests to find the virus. They also looked at tissue samples under a microscope. This confirmed that the cows really had the virus and the cancer.

The global picture shows a decline. The virus is less common now than before. But the local picture in Hubei is very different. In that province, the virus was found in nearly half of the cows tested. That is a 49 percent rate.

To put that in perspective, if you have a box of 100 apples, you would find the virus in 49 of them. That is a huge number. The study found that older cows were more likely to be infected. Cows over 12 months old had much higher rates.

The virus type found was called genotype G6. This specific type is known to be dangerous. It causes the cancer that kills the cows. The study proved that the virus is not just hanging out; it is actively causing disease in these specific farms.

But there is a catch. The good news is that the rest of the world is doing better. The bad news is that one region is struggling hard. This means that what works in Europe or America might not work in Hubei. Each place needs its own plan.

Scientists say that averages can be misleading. A global average of 23 percent sounds okay. But it hides a 49 percent problem in one place. Experts warn that we must not ignore local outbreaks just because the world average is low.

They suggest that farmers need to be more careful. They need to check their herds often. They need to keep new animals clean and separate. This is called biosecurity. It means keeping bad things out and keeping good things in.

If you are a farmer, this news is a wake-up call. You cannot assume your farm is safe just because the world is safe. You must test your own animals. Talk to your vet about testing older cows.

If you are a consumer, know that food safety is being taken seriously. Researchers are working hard to stop this virus. They want to protect the food supply. You can help by supporting farms that follow strict safety rules.

This study has some limits. It looked at data from 2010 to 2025. Some of the data was from older studies. The methods used in the past might not be as good as today's tests. Also, the study focused heavily on China. We need more data from other countries to see if this is happening there too.

What happens next? The researchers say we need immediate action. We need better testing in China. We need to teach farmers how to stop the spread. We also need to make sure the virus does not jump to other animals or people.

This virus is not a cure away. It is a long-term battle. It will take years to clear the virus from farms. But we can slow it down. By watching closely and acting fast, we can protect our cattle and our food. The fight is far from over, but we have the tools to win.

Study Details

Study typeMeta analysis
EvidenceLevel 1
Follow-up12.0 mo
PublishedJan 2026
View Original Abstract ↓
BACKGROUND: Bovine leukemia virus (BLV), the causative agent of enzootic bovine leukosis (EBL), causes substantial economic losses in the global cattle industry. While some regions have made progress in terms of control, the global epidemiological landscape and situation in China have not been fully elucidated. This study aimed to clarify the current global prevalence of BLV based on existing reported studies and investigate its alarming resurgence in China. METHODS: We conducted an integrated study comprising a systematic review and meta-analysis of the global literature from 2010 to 2025 and a detailed case series investigation from Hubei Province, China. The meta-analysis followed PRISMA guidelines to calculate the pooled prevalence and identify risk factors. The case series included pathological examination, histopathology, and molecular detection (real-time PCR and nested PCR) to confirm BLV infection and genotype in clinical cases. RESULTS: The meta-analysis, which included 44 studies, revealed a global pooled BLV prevalence of 23.24%, with a significant decline observed in studies published after 2018 (4.35%) compared with those published before 2018 (20.31%). Subgroup analyses indicated marked differences in detection rates across sample types and detection methods. Besides, significantly greater prevalence was also observed in cattle more than 12 months. In stark contrast to this global trend, the pooled prevalence in China was 16.80%, which masked a severe high-burden endemicity in Hubei Province, where a 49.41% positivity rate (126/255) was detected across three farms. Pathological and molecular analyses of four clinical cases from these farms confirmed BLV-induced lymphosarcoma and identified the circulating virus as genotype G6. CONCLUSION: This study delineates an apparent decline in reported BLV prevalence globally, contrasted with a severe localized resurgence in Hubei Province, China: an apparent decline in reported prevalence based on the available data in BLV prevalence, alongside a severe and ongoing resurgence in a major Chinese cattle-farming region. These findings underscore that national and global averages can obscure dangerous local epidemics. The situation in Hubei serves as a crucial warning, demanding immediate, targeted interventions, including enhanced surveillance, stringent biosecurity, and farmer education, to curb the spread of BLV.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.